http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005123086-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c82d3fcc623c99aef8649b8635cdd37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_445c9b8ca89c97e90872aee11ea2bc8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029263219611775e1679ecfeaba20327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b2710fc436b8878c41e7b12250bba5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_080646fc2ee2f934ea738dec6cf531cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e61263b84630539d1fc5281e3bd9ac4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f743da828c6871b3ceb90b10c361d9e7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af0f2dc5c25293f4989e73ca6ec3031e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725843135ae74eacf290c6cc7298cc98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d2fb72139ebb868330f144f9d2f657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f884a28e389a0e319482316e0e845e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffaf2b68e37557297ff750aa0306b6fe
publicationDate 2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005123086-A3
titleOfInvention Ziprasidone dosage form
abstract Pharmaceutical formulations of ziprasidone comprise ziprasidone or a salt thereof, in the form of particles having a mean particle size greater than about 90 µm and a pharmaceutically acceptable excipient.
priorityDate 2004-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004121003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003219489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6150366-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507324

Total number of triples: 30.